Overexpression of cellular FLICE-inhibitory protein (FLIP) in gastric adenocarcinoma

Clinical Science

Volumn 106, Issue 4, 2004, Pages 397-405

  Zhou, Xiao Dong ^a   Yu, Jie Ping ^a   Liu, Jin ^a   Luo, He Sheng ^a   Chen, Hong Xia ^a   Yu, Hong Gang ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Adenocarcinoma; Apoptosis; FLICE inhibitory protein (FLIP); Gastric adenocarcinoma; Metastasis; Tumour progression

Indexed keywords

BIOLOGICAL MARKER; FLICE INHIBITORY PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; NICK END LABELING; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; STOMACH ADENOCARCINOMA; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BLOTTING, WESTERN; CARRIER PROTEINS; CASE-CONTROL STUDIES; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 2142821427     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20030238     Document Type: Article

References (44)

1. Pisani, P., Parkin, D. M., Bray, F. and Ferlay, J. (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer 80, 18-29
2. Hundahl, S. A., Phillips, J. L. and Menck, H. R. (2000) The national cancer data base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy. Cancer 88, 921-932
3. Vaux, D. L. and Strasser, A. (1996) The molecular biology of apoptosis. Proc. Natl. Acad. Sci. U.S.A. 93, 2239-2244
4. Thompson, C. B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science (Washington, D.C.) 267, 1456-1462
5. Kania, J., Konturek, S. T., Marlicz, K., Hahn, E. G. and Konturek, P. C. (2003) Expression of survival and caspase-3 in gastric cancer. Dig. Dis. Sci. 48, 266-271
6. Unger, Z., Molnar, B., Pronai, L., Szaleczky, E., Zagoni, T. and Tulassay, Z. (2003) Mutant p53 expression and apoptotic activity of Helicobacter pylori positive and negative gastritis in correlation with the presence of intestinal metaplasia. Eur. J. Gastroenterol. Hepatol. 15, 389-393
7. WAF1/CIP1 and cyclin D1 are associated with malignant transformation in gastric hyperplastic polyps. Am. J. Clin. Pathol. 115, 224-234
8. Park, W. S., Oh, R. R., Kim, Y. S. et al. (2001) Somatic mutations in the death domain of the Fas (Apo-1/CD95) gene in gastric cancer. J. Pathol. 193, 162-168
9. Dhein, J., Walczak, H., Baumler, C., Debatin, K. M. and Krammer, P. H. (1995) Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature (London) 373, 438-441
10. Leithauser, F., Dhein, J., Mechtersheimer, G. et al. (1993) Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69, 415-429
11. Bennett, M. W., O'Connell, J., O'Sullivan, G. C. et al. (1999) Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer. Gut 44, 156-162
12. Koyama, S., Koike, N. and Adachi, S. (2001) Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape in gastric carcinoma. J. Cancer Res. Clin. Oncol. 27, 20-26
13. Lim, S. C. (2003) Fas-related apoptosis in gastric adenocarcinoma. Oncol. Rep. 10, 57-63
14. Thome, M., Schneider, P., Hofmann, K. et al. (1997) Viral Flice inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature (London) 386, 517-521
15. Hu, S., Vincenz, C., Ni, J., Gentz, R. and Dixit, V. M. (1997) I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD95-induced apoptosis. J. Biol. Chem. 272, 17255-17257
16. Bertin, J., Armstrong, R. C., Ottilie, S. et al. (1997) Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. U.S.A. 94, 1172-1176
17. Irmler, M., Thome, M., Hahne, M. et al. (1997) Inhibition of death receptor signals by cellular FLIP. Nature (London) 388, 190-195
18. Goltsev, Y. V., Kovalenko, A. V., Arnold, E., Varfolomeev, E. E., Brodianskii, V. M. and Wallach, D. (1997) CASH, a novel caspase homologue with death effector domains. J. Biol. Chem. 272, 19641-19644
19. Shu, H. B., Halpin, D. R. and Goeddel, D. V. (1997) Casper is a FADD- and caspase-related inducer of apoptosis. Immunity 6, 751-763
20. Inohara, N., Ding, L., Chen, S. and Nunez, G. (1997) Harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-XL. EMBO J. 16, 1686-1694
21. Srinivasula, S. M., Ahmad, M., Ottilie, S. et al. (1997) FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/ TNFR1-induced apoptosis. J. Biol. Chem. 272, 18542-18545
22. Han, D. K., Chaudhary, P. M., Wright, M. E. et al. (1997) MRIT, a novel death-effector domain-containing protein, interacts with caspases and Bcl-XL and initiates cell death. Proc. Natl. Acad. Sci. U.S.A. 94, 11333-11338
23. Rasper, D. M., Vaillancourt, J. P., Hadano, S. et al. (1998) Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD95 (Fas, APO-1) receptor complex. Cell Death Differ. 5, 271-288
24. Scaffidi, C., Schmitz, I., Krammer, P. H. and Peter, M. E. (1999) The role of c-FLIP in modulation of CD95-induced apoptosis. J. Biol. Chem. 274, 1541-1548
25. Xiao, C., Yang, B. F., Asadi, N., Beguinot, F. and Hao, C. (2002) Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells. J. Biol. Chem. 277, 25020-25025
26. Ryu, B. K., Lee, M. G., Chi, S. G., Kim, Y. W. and Park, J. H. (2001) Increased expression of c-FLIP (L) in colonic adenocarcinoma. J. Pathol. 194, 15-19
27. Sinicrope, F. A, Ruan, S. B., Cleary, K. R., Stephens, L. C., Lee, J. J. and Levin, B. (1995) Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 55, 237-241
28. Kerr, J. F., Winterford, C. M. and Harmon, B. V. (1994) Apoptosis. Its significance in cancer and cancer therapy. Cancer 73, 2013-2026
29. Meterissian, S. H. (1997) Apoptosis: its role in the progression of and chemotherapy for carcinoma. J. Am. Coll. Surg. 184, 658-666
30. Griffith, T. S., Chin, W. A., Jackson, G. C., Lynch, D. H. and Kubin, M. Z. (1998) Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J. Immunol. 161, 2833-2840
31. Thomas, R. K., Kallenborn, A., Wickenhauser, C. et al. (2002) Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells. Am. J. Pathol. 160, 1521-1528
32. Lee, S. H., Kim, H. S., Kim, S. Y. et al. (2003) Increased expression of FLIP, an inhibitor of Fas-mediated apoptosis, in stomach cancer. APMIS 111, 309-314
33. Granville, D. J., Carthy, C. M., Hunt, D. W. and McManus, B. M. (1998) Apoptosis: molecular aspects of cell death and disease. Lab. Invest 78, 893-913
34. Holmgren, L., O'Reilly, M. S. and Folkman, J. (1995) Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med. 1, 149-153
35. Yu, H. G., Li, J. Y., Yang, Y. N. et al. (2003) Increased abundance of cyclooxygenase-2 correlates with vascular endothelial growth factor-A abundance and tumor angiogenesis in gastric cancer. Cancer Lett. 195, 43-51
36. Ohta, M., Konno, H., Tanaka, T. et al. (2003) The significance of circulating vascular endothelial growth factor (VEGF) protein in gastric cancer. Cancer Lett 192, 215-225
37. Ishikawa, M., Kitayama, J., Kazama, S. and Nagawa, H. (2003) Expression of vascular endothelial growth factor C and D (VEGF-C and -D) is an important risk factor for lymphatic metastasis in undifferentiated early gastric carcinoma. Jpn. J. Clin. Oncol. 33, 21-27
38. Amioka, T., Kitadai, Y., Tanaka, S. et al. (2002) Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa. Eur. J. Cancer 38, 1413-1419
39. Kido, S., Kitadai, Y., Hattori, N. et al. (2001) Interleukin 8 and vascular endothelial growth factor-prognostic factors in human gastric carcinomas? Eur. J. Cancer 37, 1482-1487
40. Kabashima, A., Maehara, Y., Kakeji, Y. and Sugimachi, K. (2001) Overexpression of vascular endothelial growth factor C is related to lymphogenous metastasis in early gastric carcinoma. Oncology 60, 146-150
41. Yoshikawa, T., Tsuburaya, A., Kobayashi, O. et al. (2000) Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma. Cancer Lett. 153, 7-12
42. Yonemura, Y., Endo, Y., Fujita, H. et al. (1999) Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin. Cancer Res. 5, 1823-1829
43. Suhara, T., Mano, T., Oliveira, B. E. and Walsh, K. (2001) Phosphatidylinositol 3-kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP). Circ. Res. 89, 13-19
44. Kamphaus, G. D., Colorado, P. C., Panka, D. J. et al. (2000) Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J. Biol. Chem. 275, 1209-1215